Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Novartis AG ADS (NY: NVS)
74.15 USD  -0.86 (-1.15%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Novartis AG ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Stocks steady before manufacturing data
April 01, 2013
U.S. stocks hold near record highs as Wall Street looks to a report on U.S. manufacturing. Read More
category Aerospace , Market News , TSLA , and 13 more.
from MarketWatch
Monday’s movers: Tesla, BlackBerry, Apple
April 01, 2013
Shares of Tesla Motors Inc. gained on Monday as pharmaceutical companies like Novartis AG and technology stocks including Apple Inc. and BlackBerry attracted investor attention Read More
category BBRY , Computer Software , Retail , and 28 more.
from MarketWatch
Early Movers: WMT, PCS, AXP & More
April 01, 2013
These are the stocks posting the largest moves before the bell. Read More
category Cisco Systems Inc , Tesla Motors , Apple Inc , and 21 more.
from CNBC.com News
Stock futures point south ahead of ISM data
April 01, 2013
U.S. stock market futures tip lower on Monday as investors return to work after a long holiday weekend against the backdrop of weaker Asian markets. Data due later is expected to show further... Read More
category BBRY , Computer Software , SPM3 , and 21 more.
from MarketWatch
Novartis Loses Important Patent Battle
April 01, 2013
 Read More
category NYSE:NVS , Hot Stocks
from InvestorPlace - Latest Headlines
India rejects Novartis plea on cancer-drug patent
April 01, 2013
India’s Supreme Court decides against granting patent protection to Novartis’s blockbuster cancer drug Glivec, in a landmark judgment that delivers far-reaching ramifications for multinational... Read More
category Aerospace , General , NVS , and 5 more.
from MarketWatch
Biogen Prices New MS Drug Below Competitor, Prepares For Marketing Battle
March 29, 2013
Biogen Idec will price it's new multiple sclerosis pill, Tecfidera, at a wholesale acquisition cost of $54,900 per patient per year. The medicine will distributed, stocked, and available to patients... Read More
category NASDAQ:TEVA , NYSE:NVS , NYSE:SNY , and 1 more.
from Forbes Real Time
A Safer Play on the Biotech Bonanza
March 29, 2013
This Israel-based drug company combines groundbreaking innovation with large-cap stability, as it pursues new and lucrative avenues of cancer treatment. Read More
from Update Content Feed for Financial Content
Noteworthy ETF Inflows: VEA, NVS, RDS.A, GSK
March 28, 2013
Symbols mentioned in this story: VEA, NVS, RDS. , GSK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. Read More
category ETFs
from ETF Channel
Novartis Crosses Below its 10-day MA (NVS)
March 27, 2013
from Comtex SmarTrend® News Briefs
Anacor Rallies On AN2728 Progress & Market Attention
March 26, 2013
Anacor Pharmaceuticals (NASDAQ: ANAC) continues to hold onto most of the ~70% gains made throughout the last week after the company reported the results of a successful Phase II dose-ranging trial for... Read More
category ANAC , Brian L/ Wilson
from Bio-Wire.Com
Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)
March 23, 2013
Some smaller health care companies saw unusual movement in their stocks on Friday. And not just in Anacor Pharmaceuticals (NASDAQ: ANAC ), Halozyme Therapeutics (NASDAQ: HALO ), Puma Biotechnology... Read More
category SGEN , Puma Biotechnology , OPK , and 24 more.
from Latest Articles from Benzinga.com
ProPublica's "Dollars for Docs": Will The Physician Payments Sunshine Provisions Clear The Haze?
March 20, 2013
On February 1, 2013, the Centers for Medicare and Medicaid Services (CMS) published the long-delayed final rule that is intended to implement the Physician Payments Sunshine provisions that were... Read More
category NYSE:NVS , NYSE:MRK , NYSE:GSK , and 2 more.
from Forbes Real Time
JPMorgan Upgrades Novartis (NVS) to Overweight
March 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8188332 for the full story. Read More
from StreetInsider.com News Articles
JPMorgan Upgrades Novartis to “Overweight” (NVS)
March 15, 2013
JPMorgan reported on Friday that it has upgraded healthcare product giant, Novartis AG (NVS). The firm has increased its rating for the company from “Neutral” to “Overweight.” An analyst from the firm... Read More
category nvs , Dividend Stocks , novartis ag
from Dividend Daily
Upgrade Alert for Novartis (NVS)
March 15, 2013
from Comtex SmarTrend® News Briefs
How to Play Today’s All-Too-Familiar Market
March 14, 2013
 Read More
category NYSE:NVS , Market Outlook , NYSE:MUE
from InvestorPlace - Latest Headlines
Noteworthy ETF Inflows: VEA, NSRGY, HBC, NVS
March 12, 2013
Symbols mentioned in this story: VEA, NSRGY, HBC, NVS Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Actavis (ACT) Affirms Patent Challenge on Exelon Patch (NVS)
March 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8169087 for the full story. Read More
from StreetInsider.com News Articles
In Bold, Smart Move, Merck Makes Roger Perlmutter Its Research Chief, Jettisoning Peter Kim
March 07, 2013
Roger Perlmutter, who left Merck for Amgen more than a decade ago because he didn't think then-chief executive Ray Gilmartin was moving fast enough to adopt new research-and-development strategies,... Read More
category NYSE:NVS , NYSE:MRK , NASDAQ:AMGN
from Forbes Real Time
3 ADR ETFs Your Broker Forgot to Mention
March 05, 2013
The world of investing is littered with acronyms. Two of the most prominent are ETFs for "exchanged-traded funds" and ADR for "American depositary receipts" -- or shares of foreign companies that are... Read More
category LAZ , Specialty ETFs , Emerging Market ETFs , and 24 more.
from Latest Articles from Benzinga.com
PatientsLikeMe Is Building A Self-Learning Healthcare System
March 01, 2013
When we get sick, doctors capture all kinds of data about us in their office or at the hospital: bloodwork, scans, interviews, probes. Then there's a follow-up appointment to see how we're doing. Maybe... Read More
category NYSE:NVS
from Forbes Real Time
What One Novartis Researcher Would Do With Google Glass
February 27, 2013
Among the fascinating Google Glass ideas circulating on the #ifihadglass tag over on Google Plus is this wonderful notion from a researcher at Novartis. I happened to see it and thought it was really... Read More
category NYSE:NVS
from Forbes Real Time
Novartis Rising Today on Above-Average Volume (NVS)
February 25, 2013
from Comtex SmarTrend® News Briefs
Insights on Options Trading Activity for Novartis AG (NVS)
February 25, 2013
NEW YORK (AVAFIN) -- A total of 247,333 call and 24,631 put contracts were ... Read More
from AVAFIN
Billionaires Anoint Biogeeks
February 21, 2013
Hey Nobel Prize in Medicine! You've got competition. This morning, a bevy of techoscenti billionaires including Mark Zuckerberg and Sergey Brin announced the first recipients of their Breakthrough... Read More
category NASDAQ:GOOG , NYSE:NVS , NASDAQ:FB , and 2 more.
from Forbes Real Time
Dead Cat Bounce Likely in the S&P
February 21, 2013
 Read More
category NYSE:NVS , NYSE:GM , NYSE:MO , and 1 more.
from InvestorPlace - Latest Headlines
InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8115225 for the full story. Read More
from StreetInsider.com News Articles
Novartis' Exorbitant Pay Package For Former CEO Was More Ridiculous Than It Looked
February 19, 2013
So there was a big kerfluffle in Switzerland because Novartis, the drug giant, had agreed to give its departing chairman, Daniel Vasella, as much as $78 million as part of a non-compete contract. In... Read More
category NYSE:NVS , NYSE:PFE
from Forbes Real Time
Novartis (NVS) Cancels Non-Compete with Dr. Daniel Vasella
February 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8109793 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here